Back to School: How biopharma can reboot drug development. Access exclusive analysis here

RheothRx Injection: Partner Burroughs Well-come began Phase I trial to test whether RheothRx increases the efficacy of Alkeran by enhancing tumor blood flow and

CytRx Corp. (CYTR)
Product: RheothRx

Read the full 57 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE